The subject matter disclosed herein relates to cleansing swabs loaded with a cleansing fluid such as an alcohol-based cleansing fluid for disinfecting the site of a needle injection, and, more particularly, to a new and useful article and method for integrating a cleansing swab with a needle pen cap assembly to facilitate packaging, storage, handling and transport of such cleansing swabs prior to use.
Fluid medications, such as insulin for diabetes, fertility hormones, or antihistamines for allergies, are often self-administered by the affected patient. Such fluid medications generally replenish or reproduce enzymes/hormones which are not properly or appropriately being produced by one of the body's organs or glands. For example, needle pens are typically used to inject a fairly precise quantity of insulin to patients with diabetes to augment or replace a lack of insulin produced by the pancreas. Inasmuch as the level of insulin must be maintained at a fairly precise level, injections of insulin may be given several times in the course of a day. It will be appreciated, therefore, that an injection site, if used regularly, can become irritated or infected if not cared for properly.
Such fluid medications are typically integrated into a needle pen having a needle cannula in fluid communication with a vial of medication. As pressure is applied to the injection site, the body of the needle pen telescopes to apply pressure to a syringe plunger which injects the medication through the output end of the needle cannula.
As previous mentioned, a typical diabetes patient will require injections of insulin several times during the course of a single day. While the typical regiment for administration may be in the privacy of a patient's home, it is not uncommon for the fluid mediation to be administered in public locations, such as places of employment, restaurants, or during travel. With respect to the latter, it will be appreciated that such locations are not sterile and, as such, present an increased opportunity for the transmission of bacteria and/or other infectious disease. That is, there may be no opportunity to clean the site of the injection with a cleansing fluid such as with an alcohol, iodine or other liquid cleanser.
To facilitate the preparation and sterilization of the needle penetration site, manufacturers of the needle pens generally suggest that a user acquire a bottle of cleansing fluid, cotton swabs, and cleansing gauze for the purposes of preparation and sterilization of the injection site. Unfortunately, the user often forgets to include such additional materials/supplies when travelling with the needle pen/vials of medication. As such, the user will typically forego cleaning the site of penetration and risk contracting potentially harmful pathogens or a dangerous contagion.
A need, therefore, exists for a simple, sanitary article and method for cleaning an injection site prior to delivery of liquid medication, which article may be included with other items for administering medication injection and which method may be conducted without a need for planning, preparation, or a significant amount of forethought.
So that the manner in which the features of the invention can be understood, a detailed description of the invention may be had by reference to certain embodiments, some of which are illustrated in the accompanying drawings. It is to be noted, however, that the drawings illustrate only certain embodiments of this invention and are, therefore, not to be considered limiting of its scope, for the scope of the invention encompasses other equally effective embodiments. The drawings are not necessarily to scale, emphasis generally being placed upon illustrating the features of certain embodiments of the invention. In the drawings, like numerals are used to indicate like parts throughout the various views. Differences between otherwise like parts may cause to those parts to be indicated with different numerals. Different parts are indicated with different numerals. Thus, for further understanding of the invention, reference can be made to the following detailed description, read in connection with the drawings in which:
A needle cap assembly is provided for use in combination with a needle pen comprising: (i) a needle cap having a needle cannula for injecting a fluid medication into an injection site, (ii) an internal cap configured to be disposed over an injection end of the needle cap, (iii) an end cap having a cavity configured to envelop the internal and needle caps, (iv) a sealing tab configured to seal a cavity of the external cap for enclosing or housing the needle cap assembly, and (v) a cleansing swab disposed in internally of the needle cap assembly. The cleansing swab includes an absorptive material loaded with a cleansing fluid to clean an injection site prior to injection of fluid medication.
The present disclosure is directed to an article and method for preparing an injection site prior to delivery of a liquid medication, and, more particularly, to an article and method for preparing an injection site prior to and/or, for receipt of, a liquid medication by a needle pen. The needle pen includes a container for storing a vial, or supply of, liquid medication such as insulin, antihistamines, blood thinners, hormones etc. As mentioned in the Background of the disclosure, such liquid medications generally replenish/reproduce enzymes/hormones which are not properly, or appropriately, produced by an organ or gland of the body. Furthermore, there is a regular need to sterilize, or clean the site of an injection to prevent the spread of a potentially harmful bacteria or virus.
In one embodiment, the cleansing swab 14 may be disposed in combination with another internal component of the needle cap assembly 10 including, (i) a needle cap 22 having a needle cannula 22N disposed through a web portion of the needle cap 22, (ii) an internal cap 24 configured to cover an injection end 25 of the needle cannula 22N, (iii) an external cap 26 configured to envelope the needle and internal caps 22, 24, and a (iv) sealing tab 28 configured to seal a cavity 34 of the external cap 26. In the described embodiment, the cleansing swab 14 includes an absorptive gauze 16, which is loaded/doped with the cleansing fluid, and adhesively-bonded to an internal surface of the needle pen cap assembly 10. In this embodiment, the cleansing swab 14 may be disposed in combination with an underside surface of the sealing tab 28. That is, since the sealing tab 28 produces a vapor-locked cavity 34 upon being sealed against the rim flange 38 of the external cap 26, the cleansing fluid will be protected from drying air and not evaporate from the loaded gauze 14.
In another embodiment, the cleansing swab 14 may be sealed within a self-contained impervious packet 40, and bonded to the underside surface of the sealing tab 28. By sealing the self-contained impervious packet 40 internally of the needle pen cap 22, the absorptive gauze 16 is redundantly protected, i.e., by the impervious packet 40 and the sealed needle cap assembly 10.
In
Operationally, and referring to
In another embodiment of the disclosure depicted in
In another embodiment of the disclosure depicted in
In yet another embodiment shown in
In summary, a cleansing swab or gauze 14, 16, 18 is placed internally of the needle cap assembly. The cleansing swab may be disposed in combination with any of the individual components of the needle cap assembly 10 provided that the component provides a liquid or moisture tight seal with other components of the needle cap assembly 10. As such the cleansing swab or gauze 14, 16, 18 is sealed within the needle cap assembly 10 and replaces the need to carry separate alcohol swabs or a cotton balls moistened with alcohol. That is a separate container of alcohol, absorptive gauze and/or cotton balls need not be carried inasmuch as the cleansing swab 14 is integrated with an element or component of the needle cap assembly 10.
To the extent that the claims recite the phrase “at least one of” in reference to a plurality of elements, this is intended to mean at least one or more of the listed elements, and is not limited to at least one of each element. For example, “at least one of an element A, element B, and element C,” is intended to indicate element A alone, or element B alone, or element C alone, or any combination thereof. “At least one of element A, element B, and element C” is not intended to be limited to at least one of an element A, at least one of an element B, and at least one of an element C.
This written description uses examples to disclose the invention, including the best mode, and also to enable any person skilled in the art to practice the invention, including making and using any devices or systems and performing any incorporated methods. The patentable scope of the invention is defined by the claims, and may include other examples that occur to those skilled in the art. Such other examples are intended to be within the scope of the claims if they have structural elements that do not differ from the literal language of the claims, or if they include equivalent structural elements with insubstantial differences from the literal language of the claims.
This application is a non-provisional of, and claims the benefit and priority of, U.S. Provisional Patent Application No. 62/650,380, filed on Mar. 30, 2018. The complete specification of such application is hereby incorporated by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
4026287 | Haller | May 1977 | A |
4507117 | Vining | Mar 1985 | A |
4643200 | Jennings, Jr. | Feb 1987 | A |
4650468 | Jennings, Jr. | Mar 1987 | A |
4675005 | DeLuccia | Jun 1987 | A |
4692156 | Haller | Sep 1987 | A |
4710170 | Haber et al. | Dec 1987 | A |
4747830 | Gloyer et al. | May 1988 | A |
4790822 | Haining | Dec 1988 | A |
4950251 | Haining | Aug 1990 | A |
5112316 | Venturini | May 1992 | A |
5147328 | Dragosits et al. | Sep 1992 | A |
5244465 | Michel | Sep 1993 | A |
5342323 | Haining | Aug 1994 | A |
5941857 | Nguyen | Aug 1999 | A |
5989229 | Chiappetta | Nov 1999 | A |
7393345 | Yang | Jul 2008 | B2 |
8883499 | Hedrick et al. | Nov 2014 | B2 |
20090041619 | Cady et al. | Feb 2009 | A1 |
20090297400 | Cady et al. | Dec 2009 | A1 |
20110184382 | Cady | Jul 2011 | A1 |
20120111368 | Rahimy | May 2012 | A1 |
20130053751 | Holtham | Feb 2013 | A1 |
20150231289 | Webb | Aug 2015 | A1 |
20160220762 | Goral | Aug 2016 | A1 |
20170027817 | Thorne, Jr. et al. | Feb 2017 | A1 |
20180296772 | Chu | Oct 2018 | A1 |
20190009074 | Drmanovic | Jan 2019 | A1 |
Number | Date | Country | |
---|---|---|---|
20190298981 A1 | Oct 2019 | US |
Number | Date | Country | |
---|---|---|---|
62650380 | Mar 2018 | US |